In this session you will learn:

• The pathophysiology, morbidity, and mortality associated with end stage heart failure
• How to identify and when to refer your patients with heart failure to an advanced heart failure specialist 
• The different therapies available for patients with advanced heart failure

Steven Antoine, MD, Assistant Professor

In this session you'll:

• Become knowledgeable regarding HIV incidences and comorbidities in the older patient in today's day and age
• Become aware of the most common reasons for hospital admission as well as ICU admission in persons living with HIV
• Understand the management of the HIV patient who is hospitalized as well as the role of antiretroviral therapy during hospitalization

Andrea Sciberras, DO, FACOI, Medical Director, Division of Disease Control and Health Protection, Florida Department of Health

In this session you'll learn:

• FDA approved PAH drugs in light of the newest guidelines
• Drug category updates
• Future directions in the treatment of PAH

Mary R. Suchyta, DO, FACOI, Medical Director, Select Health

In this session you'll learn:

• To implement updated evidence from recent articles into hospital based patient care
• To critically analyze scientific articles and journals applicable to hospital medicine
• Treatment modalities best suited for improvement in patient outcomes

Andrew Buelt, DO, Assistant Professor of Family Medicine in the University of Central Florida (UCF), College of Medicine

In this session you will:

• Evaluate the evidence supporting the use of SGLT2 inhibitors in the management of heart failure, including their impact on cardiovascular outcomes
• Discuss the limitations in the trials used for FDA approval of the SGLT2 inhibititor
• Understand the difference in benefit with SGLT2 inhibitors between systolic and diastolic dysfunction

Andrew Buelt, DO, Assistant Professor of Family Medicine in the University of Central Florida (UCF), College of Medicine

In this session you'll learn:

• Updates in management of sleep in hospitalized patients
• To modify sleep components to improve patient outcomes in hospitalized settings
• About medications for sleep

Michelle F. Zetoony-Nudell, DO, FACOI, Clinician and Owner, DO Sleep Solutions, Inc

Approaching the Apnea Patient: Obstructive to Central (2024)

Lisa Whims-Squires, DO, FACOI

In this session you'll learn:

• To distinguish hypertensive crises from essential hypertension
• Management strategies for inpatient and outpatient hypertension management
• The pertinence of hypertension management to stroke risk reduction and management

John Dahdah, DO, Staff Physician, AdventHealth Tampa

In this session you'll learn to:

• Define biosimilars in inflammatory diseases
• Describe issues of concern in the use of biosimilars in clinical practice
• Summarize team strategies for improving care coordination and communication to advance the use of biosimilars in treating patients with inflammatory diseases 

Brinda Joshi, DO, Attending Rheumatologist, DULY Health and Care